Inpatient UTI Management

Primary Treatment: Antimicrobial Therapy

The European Urology guidelines recommend initiating empirical IV combination therapy immediately for complicated UTI with systemic symptoms, using regimens such as amoxicillin plus an aminoglycoside, second-generation cephalosporin plus an aminoglycoside, or third-generation cephalosporin IV monotherapy, due to higher resistance rates and broader microbial spectra 1, 2, 3.
The treatment duration for complicated UTI is recommended to be 7-14 days total, with 14 days for men when prostatitis cannot be excluded, and may be shortened to 7 days if the patient is hemodynamically stable and afebrile for ≥48 hours 2, 3.
Obtaining urine culture and susceptibility testing before starting antibiotics is mandatory for all hospitalized patients with UTI to guide tailored therapy 1, 2.

For catheter-associated UTI, aggressive IV antimicrobial therapy per complicated UTI protocols is required, along with catheter removal if feasible 1, 3.
The European Urology guidelines advise against using ciprofloxacin or other fluoroquinolones empirically if local resistance is >10%, the patient is from the urology department, has used fluoroquinolones in the last 6 months, or requires hospitalization 1, 2, 3.
Addressing any urological abnormality or complicating factor, such as obstruction or foreign body, is mandatory for successful treatment 1, 2.

Delaying urine culture to start phenazopyridine is not recommended, and instead, obtaining culture first, then starting both antibiotics and phenazopyridine if needed, is advised 1, 2.
Assuming uncomplicated UTI in hospitalized patients is not recommended, as most inpatients have complicating factors requiring broader coverage 1.